Table 1 Summary of study population
Total | Patients who refused GS | Patients who allowed GS | Patients who had refused and allowed GS | Patients who had no experience with GS | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
No. | (%) | No. | (%) | No. | (%) | No. | (%) | No. | (%) | |
All | 1844 | (100) | 159 | (9) | 633 | (34) | 301 | (16) | 751 | (41) |
Sex | ||||||||||
Male | 826 | (45) | 54 | (34) | 254 | (40) | 130 | (43) | 388 | (52) |
Female | 1018 | (55) | 105 | (66) | 379 | (60) | 171 | (57) | 363 | (48) |
Age, yr | ||||||||||
18-59 | 1118 | (61) | 70 | (45) | 404 | (64) | 154 | (52) | 490 | (66) |
60-94 | 706 | (39) | 87 | (55) | 227 | (36) | 145 | (48) | 247 | (34) |
Not reported | 20 | 2 | 2 | 2 | 14 | |||||
Mean (SD) | 54 | (17) | 61 | (18) | 53 | (16) | 57 | (19) | 52 | (17) |
Median | 55 | 62 | 53 | 59 | 52 | |||||
Regularly uses prescription drugs | ||||||||||
Yes | 1085 | (59) | 140 | (88) | 440 | (70) | 239 | (80) | 266 | (36) |
No | 748 | (41) | 19 | (12) | 190 | (30) | 60 | (20) | 479 | (64) |
Not reported | 11 | 0 | 3 | 2 | 6 | |||||